Crestastatin 5 mg

Crestastatin 5 mg is a medicine authorised by Swissmedic under authorisation number 66361. The authorisation holder is Grünenthal Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 07 September 2016 and the authorisation is valid without a time limit. ATC code C10AA07 places the medicine in the group Lipid modifying agents.

  • Dispensing category B
  • Authorisation number 66361
  • ATC C10AA07
  • Synthetic medicines
Authorisation data
Authorisation number66361
NameCrestastatin 5 mg
Full nameCrestastatin 5 mg, Filmtabletten
Authorisation holderGrünenthal Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC10AA07
First authorisation07 September 2016
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Crestastatin 5 mg, FilmtablettenB07 September 2016
2Crestastatin 10 mg, FilmtablettenB07 September 2016
3Crestastatin 20 mg, FilmtablettenB07 September 2016

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130Tablette(n)C10AA0707.12.0.B
2100Tablette(n)C10AA0707.12.0.B
430Tablette(n)C10AA0707.12.0.B
5100Tablette(n)C10AA0707.12.0.B
730Tablette(n)C10AA0707.12.0.B
8100Tablette(n)C10AA0707.12.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Crestastatin 5 mg authorised in Switzerland?

Yes. Crestastatin 5 mg is authorised by Swissmedic under authorisation number 66361, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Crestastatin 5 mg have?

Crestastatin 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Crestastatin 5 mg?

The authorisation holder is Grünenthal Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com